Global Antimicrobial Peptides Market Growth 2025-2031

Global Antimicrobial Peptides Market Growth 2025-2031

The global Antimicrobial Peptides market size is predicted to grow from US$ 5.4 million in 2025 to US$ 7.5 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.

By region, North America had the highest share of sales, at about 35%.

LP Information, Inc. (LPI) ' newest research report, the “Antimicrobial Peptides Industry Forecast” looks at past sales and reviews total world Antimicrobial Peptides sales in 2024, providing a comprehensive analysis by region and market sector of projected Antimicrobial Peptides sales for 2025 through 2031. With Antimicrobial Peptides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antimicrobial Peptides industry.

This Insight Report provides a comprehensive analysis of the global Antimicrobial Peptides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antimicrobial Peptides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antimicrobial Peptides market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antimicrobial Peptides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antimicrobial Peptides.

This report presents a comprehensive overview, market shares, and growth opportunities of Antimicrobial Peptides market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides

Segmentation by Application:
Pharmaceuticals
Feed Additives
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antimicrobial Peptides market?

What factors are driving Antimicrobial Peptides market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antimicrobial Peptides market opportunities vary by end market size?

How does Antimicrobial Peptides break out by Type, by Application?